Paper · 42979397

Immunobiology and Immune-Related Toxicities of Cancer Immunotherapy: Organ-Specific Immune-Related Adverse Events, Cytokine Release Syndrome, and Immune Effector Cell-Associated Neurotoxicity Syndrome.

Kim S and 8 others. J Brown Hosp Med, 2026.

11 sourcespapers-2026-11-12-0.1.0

Cite this record

ConductScience Library. Immunobiology and Immune-Related Toxicities of Cancer Immunotherapy: Organ-Specific Immune-Related Adverse Events, Cytokine Release Syndrome, and Immune Effector Cell-Associated Neurotoxicity Syndrome. Papers, record 42979397. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42979397

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title: Immunobiology and Immune-Related Toxicities of Cancer Immunotherapy: Organ-Specific Immune-Related Adverse Events, Cytokine Release Syndrome, and Immune Effector Cell-Associated Neurotoxicity Syndrome.
Journal: J Brown Hosp Med
Year: 2026
Publication types: Journal Article, Review
PubMed: https://pubmed.ncbi.nlm.nih.gov/42979397/
DOI: https://doi.org/10.56305/001c.168550
PMC: https://pmc.ncbi.nlm.nih.gov/articles/PMC13730619/
The journal: https://conductscience.org/library/journal-index/9918917745006676
Revised in PubMed: 2026-11-05

Source PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Order	Author	Forename	ORCID iD
1	Kim S	Stanley	https://orcid.org/0009-0001-1932-7834
2	Schiffman F	Fred
3	Hadfield M	Matthew
4	Reagan J	John
5	Carneiro B	Bendito
6	Pelcovits A	Ari
7	Salk G	Gabriel
8	Gill V	Victoria
9	Safran H	Howard

Source PubMed

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References116

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

Order	PMID	Title	Journal	Year	In Papers	Source
1	32,929,051	LAG-3: from molecular functions to clinical applications.	J Immunother Cancer	2020	https://conductscience.org/library/papers/32929051	PubMed
2	32,945,632	Avelumab Maintenance Therapy for Advanced or Metastatic Urothelial Carcinoma.	N Engl J Med	2020	https://conductscience.org/library/papers/32945632	PubMed
3	37,270,183	Management of immune-related cutaneous adverse events with dupilumab.	J Immunother Cancer	2023	https://conductscience.org/library/papers/37270183	PubMed
4	34,986,285	Relatlimab and Nivolumab versus Nivolumab in Untreated Advanced Melanoma.	N Engl J Med	2022	https://conductscience.org/library/papers/34986285	PubMed
5	29,567,210	Myocarditis in Patients Treated With Immune Checkpoint Inhibitors.	J Am Coll Cardiol	2018	https://conductscience.org/library/papers/29567210	PubMed
6	29,385,370	Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia.	N Engl J Med	2018	https://conductscience.org/library/papers/29385370	PubMed
7	1,692,078	LAG-3, a novel lymphocyte activation gene closely related to CD4.	J Exp Med	1990	https://conductscience.org/library/papers/1692078	PubMed
8	24,876,563	Current concepts in the diagnosis and management of cytokine release syndrome.	Blood	2014	https://conductscience.org/library/papers/24876563	PubMed
9	28,296,676	Histopathologic Features of Colitis Due to Immunotherapy With Anti-PD-1 Antibodies.	Am J Surg Pathol	2017	https://conductscience.org/library/papers/28296676	PubMed
10	36,989,488	How I treat refractory CRS and ICANS after CAR T-cell therapy.	Blood	2023	https://conductscience.org/library/papers/36989488	PubMed

1 to 10 of 116

See all 116 references

Cited by0

The papers in our copy of PubMed whose reference list names this one, newest first.

None in this release.

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed: 2026-11-06; PubMed
iCite: 2026-11-05; iCite
PMC's ID file: 2026-11-05; PMC's ID file
NIH RePORTER's grant and paper links: 2026-11-01; NIH RePORTER's grant and paper links
Trials: 2026-11-12
Gene search: 2026-11-11
Pipelines: 2026-09-18

Sources 11

ChEMBL, through Open TargetsCC BY-SA 3.0
ClinicalTrials.govNo license stated
HGNCCC0
iCiteCC BY 4.0
NCBI GenePublic domain (US government)
NIH RePORTER's grant and paper linksPublic domain
Open TargetsCC0 1.0
PMC's ID filePublic domain (US government)
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0

Each source's terms

ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
ClinicalTrials.govnone stated
HGNCCC0: https://www.genenames.org/about/license/
iCiteCC BY 4.0
NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42979397

GET https://conductscience.org/api/papers/v1/42979397/references?page=2

API reference For AI assistants